hVIVO Rebrand

Retroscreen Virology plc -> hVIVO plc

The Challenge

As Retroscreen Virology pivoted its core business model from a clinical research service provider to an early-phase drug developer, its legacy branding no longer reflected its future capabilities or strategic vision. The company required a complete identity overhaul—encompassing name, positioning, visual identity, and tone of voice—to align with its modern ambitions.

Strategic Execution

• Brand Strategy & Naming: Orchestrated a end-to-end rebrand (Autumn 2014 – April 2015), developing the new identity, “hVIVO plc,” alongside a modernized market positioning and visual style guide.

• Agency & Resource Management: Appointed and led a top-tier creative branding agency while building and directing a dedicated in-house design capability to execute the vision.

• Stakeholder Alignment & Culture: Led an internal engagement initiative to secure buy-in across all business functions, aligning executive leadership, clinical teams, and operational staff around the new vision.

• Cross-Functional Orchestration: Managed complex multi-departmental readiness workflows to ensure total operational alignment across legal, HR, IT, and marketing functions ahead of launch day.

The Results

• Flawless Execution: Successfully launched hVIVO plc on April 16, 2015, fully on time and on budget across all touchpoints.

• Turnkey Rollout: Simultaneous release of new digital platforms, corporate website, physical signage, social channels, collateral, multimedia assets, and corporate stationery.

• Business Impact: Delivered a modern, future-ready brand platform that supported the company’s evolution into a leading player in early-phase drug development.